These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 8520247

  • 1. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
    Brown SD, Barbara AJ, Lambert T, Wilson DV.
    Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
    [Abstract] [Full Text] [Related]

  • 2. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, Islam LN, Hassan MS.
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [Abstract] [Full Text] [Related]

  • 3. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K.
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [Abstract] [Full Text] [Related]

  • 4. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G, Günalp A.
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [Abstract] [Full Text] [Related]

  • 5. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N, Ozen H, Yüce A, Gürakan F.
    Turk J Pediatr; 1998 Jan; 40(3):365-72. PubMed ID: 9763900
    [Abstract] [Full Text] [Related]

  • 7. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI.
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [Abstract] [Full Text] [Related]

  • 8. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E, Lalla T, Orphanou E, Sinakos E, Vrettou E, Raptopoulou-Gigi M.
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [Abstract] [Full Text] [Related]

  • 10. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G, Wagner J, Arnold W, Purcell RH, Meyer zum Büschenfelde KH.
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [Abstract] [Full Text] [Related]

  • 11. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 12. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR.
    Boll Ist Sieroter Milan; 1977 Mar 31; 56(1):74-8. PubMed ID: 861075
    [Abstract] [Full Text] [Related]

  • 13. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
    Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS.
    Hepatology; 1995 Nov 31; 22(5):1387-92. PubMed ID: 7590652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y.
    Am J Gastroenterol; 1986 Apr 31; 81(4):239-45. PubMed ID: 3962948
    [Abstract] [Full Text] [Related]

  • 17. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO, Galizzi Filho J, Simonetti JP, Simonetti SR, de Santana ZM, Barbosa MM, de Carvalho DG, Toppa NH.
    Rev Hosp Clin Fac Med Sao Paulo; 1998 Apr 31; 53(6):311-6. PubMed ID: 10413947
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 31; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 20. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, Kamangar F.
    Am J Gastroenterol; 2005 Apr 31; 100(4):856-61. PubMed ID: 15784032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.